NACDS States That Pharmacies Are Crucial in the Deployment of an Eventual COVID-19 Vaccine
August 3rd 2020National Association of Chain Drug Stores (NACDS) President and CEO Steven C. Anderson issued a statement on July 31 regarding the nation’s preparations for the eventual deployment of COVID-19 vaccines.
Read More
Antibiotic Use in Infants May Increase Risk of Inflammatory Bowel Disease Later in Life
July 31st 2020According to a study published in Genome Medicine, the disruption of gut bacteria through the use of antibiotics soon after birth has the ability to affect the immune system’s process of maturation.
Read More
The Role of Professionalism in the Lives of Pharmacy Technician Students
July 16th 2020At the National Pharmacy Technician Association’s virtual Pharmacy Technician Student Summit, Jamie McGuire, the pharmacy technician program director, discussed the role of professionalism in the lives of pharmacy technician students.
Read More
Update on Pharmacogenomic Testing and Use in Behavioral Health Treatment for Pediatric Patients
July 15th 2020At the 2020 Virtual Conference on Pediatric Health Care, Kimberly Erlich presented an update on current understandings of pharmacogenomic testing and its use as a tool in the treatment of behavioral health issues in a pediatric population.
Read More
Researchers Find New Standard for Blood-based Biomarkers in the Prediction of Cancer Recurrence
July 15th 2020The presence of ctDNA and CTCs in the plasma of the blood of women who have undergone chemotherapy prior to surgery for the treatment of triple-negative breast cancer (TNBC) are critical indicators in the prediction of disease recurrence and disease-free survival.
Read More
The Value of Specialty Pharmacy, Long-term Care Accreditation for Pharmacies
July 9th 2020Pharmacy Times® interviewed Tim Safley, program director of the Accreditation Commission for Health Care (ACHC), and Jon Pritchett, program director of ACHC, on the value of specialty pharmacy and LTC accreditation for pharmacies.
Read More
Study: New 15-Valent Pneumococcal Conjugate Vaccine Meets Immunogenicity and Safety Objectives
July 2nd 2020Results from 2 initial phase 3 studies evaluating an investigational 15-valent pneumococcal conjugate vaccine were recently released, assessing its immunogenicity, safety, and tolerability.
Read More